Nuala M. Mulgrew
c-Met inhibition in aHOXA9/Meis1model of CN-AML
Mulgrew, Nuala M.; Kettyle, Laura M.J.; Ramsey, Joanne M.; Cull, Susan; Smyth, Laura J.; Mervyn, Danielle M.; Bijl, Janet J.; Thompson, Alexander
Authors
Laura M.J. Kettyle
Joanne M. Ramsey
Susan Cull
Laura J. Smyth
Danielle M. Mervyn
Janet J. Bijl
ALEXANDER THOMPSON Alex.Thompson@nottingham.ac.uk
Associate Professor
Abstract
Background: Hematopoiesis is a paradigm for developmental processes, hierarchically organized, with stem cells at its origin. Hematopoietic stem cells (HSCs) replenish progenitor and precursor cells of multiple lineages, which normally differentiate into short-lived mature circulating cells. Hematopoiesis has provided insight into the molecular basis of tissue homeostasis and malignancy. Malignant hematopoiesis, in particular acute myeloid leukemia (AML), results from impaired development or differentiation of HSCs and progenitors. Co-overexpression of HOX and TALE genes, particularly the HOXA cluster and MEIS1, is associated with AML. Clinically relevant models of AML are required to advance drug development for an aging patient cohort. Results: Molecular analysis identified altered gene, microRNA, and protein expression in HOXA9/Meis1 leukemic bone marrow compared to normal controls. A candidate drug screen identified the c-Met inhibitor SU11274 for further analysis. Altered cell cycle status, apoptosis, differentiation, and impaired colony formation were shown for SU11274 in AML cell lines and primary leukemic bone marrow. Conclusions: The clonal HOXA9/Meis1 AML model is amenable to drug screening analysis. The data presented indicate that human AML cells respond in a similar manner to the HOXA9/Meis1 cells, indicating pre-clinical relevance of the mouse model.
Citation
Mulgrew, N. M., Kettyle, L. M., Ramsey, J. M., Cull, S., Smyth, L. J., Mervyn, D. M., …Thompson, A. (2013). c-Met inhibition in aHOXA9/Meis1model of CN-AML. Developmental Dynamics, 243(1), https://doi.org/10.1002/dvdy.24070
Journal Article Type | Article |
---|---|
Acceptance Date | Sep 26, 2013 |
Online Publication Date | Dec 4, 2013 |
Publication Date | Dec 20, 2013 |
Deposit Date | May 11, 2017 |
Journal | Developmental Dynamics |
Print ISSN | 1058-8388 |
Electronic ISSN | 1097-0177 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 243 |
Issue | 1 |
DOI | https://doi.org/10.1002/dvdy.24070 |
Keywords | HOXA9; Meis1; Mouse model; Leukemia; Candidate drugs |
Public URL | https://nottingham-repository.worktribe.com/output/720297 |
Publisher URL | https://doi.org/10.1002/dvdy.24070 |
Contract Date | May 11, 2017 |
You might also like
Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML
(2023)
Journal Article
The Use of Biomaterials in Internal Radiation Therapy
(2020)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search